NCT06810960View on ClinicalTrials.gov

A Postmarketing Study of Lecanemab in South Korean Participants With Alzheimer's Disease

RecruitingOBSERVATIONAL

Enrollment

3,000

Participants

Timeline

Start Date

February 24, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions

Alzheimer's Disease

Interventions

OTHER

No Intervention

This is a non-interventional study.

Trial Locations (1)

07110

RECRUITING

Eisai Trial Site #1, Nutley

All Listed Sponsors

lead

Eisai Korea Inc.

INDUSTRY